Clinical Trial Update: Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain [Phase 3]

View source ↗

Summary

Phase 3 safety and tolerability evaluation of OraVescent Fentanyl in opioid-tolerant patients with noncancer-related breakthrough pain has been completed. The u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Low Back Pain
• Migraine
• Osteoarthritis

Drugs mentioned

• OraVescent Fentanyl (fentanyl)

Snippet

Sponsor: Cephalon | Conditions: Low Back Pain, Migraine | Phase 3 | Status: COMPLETED